Company / Current Liabilities
Phio Pharmaceuticals Corp. Current Liabilities History
FY2012-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$2.2M
FY2020
5-year range
$1.7M / $2.5M
FY2016-FY2020
Trend
+16.8%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $2M to $2M over the past 2 years.
Based on SEC 10-K filings.
$2M in FY2020 with a 3-year CAGR of -1.0%.
Increased from $2M to $2M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -1.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -1.0%, indicating a declining trend.
- In FY2020, current liabilities increased 16.8% year-over-year.
- Peak current liabilities was recorded in FY2016.
- Lowest current liabilities in the period was in FY2012.
Company context
Key Data Points
- Altman Z-Score -0.94 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $2.2M | +16.8% |
| FY2019 | $1.9M | +7.8% |
| FY2018 | $1.7M | -23.0% |
| FY2017 | $2.3M | -10.9% |
| FY2016 | $2.5M | +22.4% |
| FY2013 | $2.1M | +23.6% |
| FY2012 | $1.7M | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026